MagnaPharm Consortium at the 50th Annual Conference of the British Association of Crystal Growth (BACG)
12h July 2019
The 50th annual conference of the British Association of Crystal Growth (BACG) took place in Central London at the Rooms On Regent’s Park, from 9th – 11th July 2019.
Co-hosted by MagnaPharm's own Professor Sally Price FRS and Dr. Matteo Salvalaglio of UCL, the 3-day conference was a great success for the group.
Day 1 saw PhD student Victoria Hamilton delivered a very well received talk on 'In situ observation of organic pharmaceutical crystal growth using liquid cell electron microscopy', following her paper recently published in Angewandte Chemie.
PhD student Charlie Hall's poster on 'Deep Eutomic Solvents' also sparked some very interesting discussions, leading him to scoop the BACG 2019 prize for 'Best Poster'- presented by renowned Professor Alan Myerson of MIT. Charlie's work presented a new class of deep eutectic solvents where one component of the system is inherently volatile, enabling a premeditated, auto-destructive capability which leads inexorably to a series of novel crystal structures. These deep eutomic solvents are easily-formed liquids with a greatly depressed melting point and exhibit all of the physical characteristics of classical deep eutectic solvents, with the exception that the hydrogen-bond donor component is volatile when exposed to the atmosphere at room temperature.
Dr Louise Price and Dr Rui Guo of UCL also displayed impressive posters on 'The Uses and Abuses of a Database of Computer Generated Crystal Structures' and 'Crystallization for novel polymorphs of organic molecular crystals in magnetic field' respectively.
Day 2 was rounded off with Dr Jason Potticary's very well attended talk to a packed room - keen to discuss the work on 'Control of polymorphism in the three organic systems through the application of strong magnetic fields during crystal growth'. Jason received some engaging questions from the floor which demonstrated the uniqueness of this novel approach to controlling crystal growth.
Dinner at the Royal Society was the perfect setting for this prestigious event which was a brilliant success for the MagnaPharm consortium.